US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 19.960
- +0.970+5.11%
Close Nov 4 16:00 ET
- 20.001
- +0.041+0.21%
Post 17:13 ET
14.72BMarket Cap-86782P/E (TTM)
20.560High18.800Low1.91MVolume19.410Open18.990Pre Close37.97MTurnover1.86%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High33.60P/B2.05BFloat Cap1.79052wk Low--Dividend TTM102.77MShs Float33.890Historical High--Div YieldTTM9.27%Amplitude0.660Historical Low19.880Avg Price1Lot Size
Summit Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -103.38%-30.3M | -12.74%-33M | -129.49%-30.13M | -84.60%-76.76M | -474.86%-19.46M | -74.13%-14.9M | -52.33%-29.27M | 30.89%-13.13M | 42.71%-41.58M | 156.55%5.19M |
| Net income from continuing operations | -164.50%-56.25M | -310.31%-60.39M | 91.98%-43.47M | -680.54%-614.93M | -90.17%-36.57M | 0.55%-21.27M | 12.25%-14.72M | -2,434.82%-542.38M | 11.08%-78.78M | 29.04%-19.23M |
| Operating gains losses | 1.98%515K | 75.97%-124K | 101.01%9K | -151.22%-1.34M | 73.41%-440K | -73.49%505K | -138.83%-516K | -185.73%-889K | 702.45%2.62M | -270.62%-1.66M |
| Depreciation and amortization | -37.50%20K | -56.52%20K | -70.00%27K | -18.46%2.05M | 215.77%1.88M | -95.51%32K | -92.22%46K | -85.37%90K | 2.40%2.51M | -11.18%596K |
| Other non cash items | 102.98%7K | ---- | ---- | 17,252.47%527.17M | -81.65%401K | -167.05%-235K | -96.77%24K | 266,050.51%526.98M | 511.27%3.04M | 12,752.94%2.19M |
| Change In working capital | 114.48%8.96M | 122.96%3M | 2,393.99%4.2M | -127.48%-2.37M | -44.77%6.72M | -44.30%4.18M | -72.04%-13.08M | 94.70%-183K | 12,959.70%8.62M | 14.34%12.17M |
| -Change in receivables | -92.47%260K | -390.57%-154K | -47.33%632K | -51.90%4.53M | -101.66%-178K | 15,790.91%3.45M | 196.36%53K | 199.09%1.2M | 231.58%9.41M | 64.01%10.7M |
| -Change in prepaid assets | -117.90%-181K | 172.41%3.55M | -943.50%-2.79M | -117.90%-914K | 2,513.86%2.64M | -73.22%1.01M | -237.42%-4.9M | -87.66%331K | 117.78%5.11M | -92.11%101K |
| -Change in payables and accrued expense | 323.30%8.97M | 125.74%1.77M | 198.00%2.16M | -115.45%-349K | 301.28%6.59M | -61.46%2.12M | -108.58%-6.86M | -37.84%-2.2M | -65.34%2.26M | -33.09%1.64M |
| -Change in other current assets | 93.85%-151K | 80.78%-275K | 398.23%2.53M | -1,691.16%-3.42M | 87.46%-43K | -224.75%-2.46M | -37.60%-1.43M | 237.30%508K | 106.73%215K | -284.41%-343K |
| -Change in other current liabilities | -58.62%24K | ---1.72M | --1.76M | -101.18%-2.21M | -990.87%-2.27M | 119.53%58K | --0 | --0 | -2.90%-1.1M | 36.00%-208K |
| -Change in other working capital | 628.57%37K | -433.33%-160K | -318.18%-92K | ---- | ---- | 99.80%-7K | 103.26%48K | 99.17%-22K | -795.20%-7.28M | -47.23%276K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -103.38%-30.3M | -12.74%-33M | -129.49%-30.13M | -84.60%-76.76M | -474.86%-19.46M | -74.13%-14.9M | -52.33%-29.27M | 30.89%-13.13M | 42.71%-41.58M | 156.55%5.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3,015.75%-108.62M | -96,756.52%-200.08M | 103.08%19.87M | -94,094.55%-587.77M | 605,580.00%60.57M | -17,530.00%-3.49M | 170.65%207K | -178,587.81%-645.06M | -103.92%-624K | 108.33%10K |
| Net PPE purchase and sale | -9.43%-58K | -130.58%-63K | 92.45%-4K | 115.71%98K | -120.00%-2K | -365.00%-53K | 170.31%206K | 85.32%-53K | -103.92%-624K | 108.33%10K |
| Net investment purchase and sale | -2,625.02%-93.55M | -20,001,700.00%-200.02M | 111.69%19.88M | ---112.86M | --60.57M | ---3.43M | --1K | ---170M | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---475.02M | --0 | --0 | --0 | ---475.02M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -3,015.75%-108.62M | -96,756.52%-200.08M | 103.08%19.87M | -94,094.55%-587.77M | 605,580.00%60.57M | -17,530.00%-3.49M | 170.65%207K | -178,587.81%-645.06M | -103.92%-624K | 108.33%10K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 89,044.98%204.14M | 250,365.00%200.21M | -99.39%485K | -86.05%86.51M | -98.80%6.25M | -99.69%229K | -80K | 218.07%80.11M | 696.04%620.24M | 41,141.87%520.06M |
| Net issuance payments of debt | ---75.5M | --0 | --0 | -104.75%-24.69M | --0 | --0 | --0 | -198.74%-24.69M | --520M | --520M |
| Net common stock issuance | --278M | ---- | ---- | --5M | --5M | --0 | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | 521.54%1.64M | --212K | -99.54%485K | 6.39%106.82M | 1,699.04%1.87M | -100.39%-390K | --0 | 56,229.95%105.34M | 3,151.26%100.4M | 100.14%104K |
| Net other financing activities | ---- | ---- | ---- | -299.35%-619K | ---- | ---- | ---80K | ---539K | 9.88%-155K | -207.32%-44K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 89,044.98%204.14M | 250,365.00%200.21M | -99.39%485K | -86.05%86.51M | -98.80%6.25M | -99.69%229K | ---80K | 218.07%80.11M | 696.04%620.24M | 41,141.87%520.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -31.73%28.75M | -13.19%61.61M | -88.99%71.43M | 803.47%648.61M | -80.49%23.79M | -26.54%42.12M | -8.37%70.97M | 803.47%648.61M | 8.09%71.79M | 51.99%121.97M |
| Current changes in cash | 459.31%65.23M | -12.77%-32.87M | 98.31%-9.78M | -200.00%-578.02M | -90.98%47.36M | -127.31%-18.15M | -49.39%-29.15M | -10,024.15%-578.08M | 11,407.82%578.04M | 6,634.72%525.26M |
| Effect of exchange rate changes | 167.06%114K | -95.90%12K | -108.11%-36K | 168.66%839K | -80.22%272K | 90.69%-170K | 148.43%293K | 367.47%444K | -448.15%-1.22M | 428.16%1.38M |
| End cash Position | 295.50%94.1M | -31.73%28.75M | -13.19%61.61M | -88.99%71.43M | -88.99%71.43M | -80.49%23.79M | -26.54%42.12M | -8.37%70.97M | 803.47%648.61M | 803.47%648.61M |
| Free cash flow | -103.04%-30.36M | -12.88%-33.07M | -128.60%-30.14M | -82.17%-76.89M | -474.18%-19.46M | -75.16%-14.95M | -50.14%-29.29M | 31.91%-13.18M | 42.10%-42.21M | 155.93%5.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data